Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1466-2026

Medline Industries, LP recalls Medline kits containing Tego Connectors Medline APHERESIS SUBQPORT ACCESS KIT SKU D…

Medline Industries, LPNorthfield, IL, United StatesReported Mar 4, 2026 · 4 months ago
Legal News Analyst ·

Reason for recall

Affected lots may exhibit issues with the silicone seal on Tego Connectors included in kits. Issues include silicone seal doming and silicone seal tearing. These issues may result in an occluded fluid path identified by the inability of the user to inject or withdraw blood product with a syringe. Damaged seals may also result in delay in therapy or fluid leakage, interruption in therapy, exposure to biological contaminants or air infused into the body.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • Medline kits containing Tego Connectors Medline APHERESIS SUBQPORT ACCESS KIT SKU DYNDA2705 Medline CENTRAL LINE INSERTION SKUDYNJ63347A
    21 affected lots
    24DBL78724HBR63025ABH69925DBV20925GBQ405DYNJ63347A1019348927806440193489278065
    +13 more24AMC87424AME13924AMH82024BMF09724CMF69124GMB76924GMK03624IMC12424LMA11025AMJ63425GMD38625IMB51025JMI708

What the firm is doing

On January 8, 2026, the firm notified affected customers of the product issue through email and first class mail. Customers were instructed to request stickers to over-label affected convenience kits with a warning label indicating to remove the affected component and replace it with product from supply. No kits are to returned.

DistributionShow details

US Nationwide distribution.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls